Oral Antiplatelet Therapy for Secondary Prevention of Non-Cardioembolic Ischemic Cerebrovascular Events

被引：3

作者：

De Luca, Leonardo ^{[1
,7
]}

Bellettini, Elisa ^{[1
]}

Di Maio, Dario ^{[2
]}

Natale, Enrico ^{[1
]}

Putini, Rita Lucia ^{[1
]}

Anticoli, Sabrina ^{[3
]}

Colivicchi, Furio ^{[4
]}

Calabro, Paolo ^{[2
]}

Musumeci, Francesco ^{[5
,6
]}

Gabrielli, Domenico ^{[1
]}

机构：

[1] Azienda Osped San Camillo Forlanini, Div Cardiol, Dept Cardiosci, I-00152 Rome, Italy

[2] Univ Campania Luigi Vanvitelli, Div Cardiol, Dept Translat Med, I-81100 Caserta, Italy

[3] Azienda Osped San Camillo Forlanini, Stroke Unit, I-00152 Rome, Italy

[4] S Filippo Neri Hosp, Div Cardiol, I-00135 Rome, Italy

[5] Azienda Osped San Camillo Forlanini, Dept Cardiosci, Cardiac Surg Unit, I-00152 Rome, Italy

[6] Azienda Osped San Camillo Forlanini, Dept Cardiosci, Heart Transplantat Ctr, I-00152 Rome, Italy

[7] Azienda Osped San Camillo Forlanini, Dept Cardiosci, UOC Cardiol, I-00152 Rome, Italy

来源：

JOURNAL OF CLINICAL MEDICINE | 2021年 / 10卷 / 08期

关键词：

antiplatelet therapy; aspirin; clopidogrel; ticagrelor; stroke; TIA; EARLY ASPIRIN USE; RISK PATIENTS; STROKE TRIAL; MINOR STROKE; CLOPIDOGREL; TICAGRELOR; ATTACK; MANAGEMENT;

D O I：

10.3390/jcm10081721

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Stroke is the leading cause of disability and mortality worldwide. After an acute cerebrovascular ischemia, recurrent vascular events, including recurrent stroke or transient ischemic accidents (TIA), occur in around 20% of cases within the first 3 months. In order to minimize this percentage, antiplatelet therapy may play a key role in the management of non-cardioembolic cerebrovascular events. This review will focus on the current evidence of antiplatelet therapies most commonly discussed in practice guidelines and used in clinical practice for the treatment of stroke/TIA complications. The antiplatelet therapies most commonly used and discussed are as follows: aspirin, clopidogrel, and ticagrelor.

引用

页数：9

共 50 条

[1] Antiplatelet Therapy in the Secondary Prevention of Non-cardioembolic Ischemic Stroke and Transient Ischemic Attack: A Mini-Review
Valis, Martin
Klimova, Blanka
Novotny, Michal
Herzig, Roman
FRONTIERS IN NEUROLOGY, 2021, 12
[2] Oral anticoagulants and non-cardioembolic stroke prevention
Schachter, Michael E.
Tran, Huyen A.
Anand, Sonia S.
VASCULAR MEDICINE, 2008, 13 (01) : 55 - 62
[3] Antithrombotic Therapy for Secondary Prevention in Patients with Non-Cardioembolic Stroke or Transient Ischemic Attack: A Systematic Review
Tornyos, Daniel
Balint, Alexandra
Kupo, Peter
El Abdallaoui, Oumaima El Alaoui
Komocsi, Andras
LIFE-BASEL, 2021, 11 (05):
[4] Oral Antiplatelet Therapy in the Secondary Prevention of Atherothrombotic Events
Geoffrey Ling
Bruce Ovbiagele
American Journal of Cardiovascular Drugs, 2009, 9 : 197 - 209
[5] Oral Antiplatelet Therapy in the Secondary Prevention of Atherothrombotic Events
Ling, Geoffrey
Ovbiagele, Bruce
AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2009, 9 (03) : 197 - 209
[6] Colchicine for the prevention of vascular events after non-cardioembolic stroke
Katsanos, Aristeidis H.
Shoamanesh, Ashkan
LANCET, 2024, 404 (10448): : 96 - 98
[7] Dual versus single antiplatelet therapy in patients with non-cardioembolic acute ischemic stroke and baseline MRI
De Marchis, Gian Marco
Toebak, Anna
Dittrich, Tolga
Vlachos, Dimitrios
Wang, Angela
Smith, Eric E.
Mundl, Hardi
Colorado, Pablo
Shoamanesh, Ashkan
Hart, Robert G.
EUROPEAN STROKE JOURNAL, 2025,
[8] ANALYSIS OF SECONDARY PREVENTION MEDICATION USE AMONG PATIENTS WITH NON-CARDIOEMBOLIC ISCHEMIC STROKE IN BEIJING
Wei, C.
Wang, Y.
Fan, D.
Pan, Y.
Han, Q.
Hu, Y.
VALUE IN HEALTH, 2017, 20 (05) : A278 - A278
[9] Acute Ischemic Cerebrovascular Events on Antiplatelet Therapy: What is the Optimal Prevention Strategy?
Milionis, Haralampos
Michel, Patrik
CURRENT PHARMACEUTICAL DESIGN, 2013, 19 (21) : 3788 - 3794
[10] Clinical Profile Of Patients With Non-cardioembolic Ischemic Stroke Or Transient Ischemic Attack Benefiting Most From Dual Antiplatelet Therapy
Qian, Shuo
Trifan, Gabriela
Testai, Fernando
STROKE, 2022, 53

← 1 2 3 4 5 →